Related Experiment Videos
[Amrinone for cardiovascular therapy in hypodynamic septic patients?]
R Fretschner1, T Klöss, U Birkenhauer
1Klinik für Anästhesiologie und Transfusionsmedizin der Universität Tübingen.
Summary
Amrinone increases cardiac output in septic patients with inadequate tissue perfusion. However, it also causes systemic vasodilation, potentially increasing the risk of myocardial ischemia.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Cardiovascular Physiology
Context:
- Sepsis presents significant hemodynamic challenges, including pulmonary hypertension and impaired oxygen delivery.
- Effective hemodynamic therapy aims to optimize cardiac output for adequate tissue oxygenation.
Purpose:
- To evaluate the efficacy of amrinone, a phosphodiesterase inhibitor, in hypodynamic septic patients with poor tissue perfusion.
- To assess amrinone's impact on cardiac output, oxygen delivery, and systemic/pulmonary hemodynamics.
Summary:
- Amrinone administration (30 µg/kg/min) significantly increased cardiac index in septic patients with low mixed venous oxygen saturation.
- While oxygen delivery and uptake improved, oxygen uptake remained supply-dependent.
- Amrinone induced pulmonary vasodilation but also pronounced systemic vasodilation, lowering mean arterial pressure.
Impact:
- Amrinone enhances cardiac output in sepsis through pulmonary vasodilation.
- Systemic vasodilation induced by amrinone may pose a risk for myocardial ischemia in septic patients.